OpenEvidence
Backed by
Raised $210M Series B on Jul 15, 2025
OpenEvidence is a next-generation AI platform transforming how healthcare professionals and organizations access and apply medical information. Built on cutting-edge large language models and deep clinical data, OpenEvidence enables faster, more reliable, and more personalized decision-making for clinicians and life sciences partners.
Explore similar companies to OpenEvidence
Fortuna Health
Helping consumers navigate Medicaid.
Orchid
Helping couples have healthy babies.
Headlight
Online therapy and mental health services.
Silna
Make care your primary focus.
Tandem Health
Medical notes that write themselves.
Eternal
Longevity care for athletes.
Anterior
Lead your health plan into the future.
Tennr
The intelligent automation platform for healthcare ops.
Collate
Empowering life sciences development.